Urine lipoarabinomannan as a marker for low-risk of NTM infection in the CF airway
Author:
Funder
National Institutes of Health
CF Foundation
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health
Reference20 articles.
1. Nontuberculous mycobacteria in cystic fibrosis: updates and the path forward;Martiniano;Pediatr Pulmonol,2017
2. Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014;Adjemian;Ann Am Thorac Soc,2018
3. Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis;Martiniano;Ann Am Thorac Soc,2014
4. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases;Griffith;Am J Respir Crit Care Med,2007
5. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary;Floto;Thorax,2016
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosis;2024-08-09
2. Diagnostic value of chemiluminescence for urinary lipoarabinomannan antigen assay in active tuberculosis: insights from a retrospective study;Frontiers in Cellular and Infection Microbiology;2023-12-08
3. Collected Thoughts on Mycobacterial Lipoarabinomannan, a Cell Envelope Lipoglycan;Pathogens;2023-10-26
4. Phylogenomics of nontuberculous mycobacteria respiratory infections in people with cystic fibrosis;Paediatric Respiratory Reviews;2023-06
5. Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators;Seminars in Respiratory and Critical Care Medicine;2023-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3